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Background: Control of blood pressure (BP) remains a challenge among patients in the public health 
system in South Africa. The objective was to assess availability of all prescribed antihypertensive 
medicines among patients with raised BP on the day they attended rural primary healthcare facilities 
(PHCs) and determine the association between medicines availability, the number of prescribed 
antihypertensive medicines and BP control.  
Methods: Secondary data from an operational study from rural PHCs in South Africa including 
patients’ demographics and BP, as well as data on medicine availability. Data analysis included 
descriptive and inferential statistics.  
Results: 55 black African patients were assessed, with 89.1% being female. Some data were not 
available for all 55 patients. The mean age was 61.3 years, and 54.6% did not have formal education. 
Two thirds (67.2%) of patients received all their antihypertensive medications whilst 25.5% received 
some of their medicines during the three months study period with no record in 7.3% of the patients. 
There was no significant relationship between receiving all antihypertensive medicines and BP 
control. The majority of patients on one antihypertensive had better BP control; however, this did not 
reach significance (p=0.069). Concerns with the lack of BP recording on all occasions in some 
patients (20%).  
Conclusion: One third of patients went home without all their antihypertensive medicines from the 
PHC facilities. Other concerns included the lack of routine BP monitoring and the number of 
prescribed medicines. Studies are ongoing to explore key issues with medicines availability and 
concerns with adherence and BP control.  
 
